Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02886312 · ClinicalTrials.gov registry record
Evaluation of Oxygen Delivery Through Nasal Cannula in Volunteers
A clinical trial of Patient Comfort and Oxygen Delivery, sponsored by University of Utah.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02886312: Completed study of Patient Comfort and Oxygen Delivery, sponsored by University of Utah.
NCT02886312 is a study of Patient Comfort and Oxygen Delivery that has completed, run by University of Utah. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02886312, a study of Patient Comfort and Oxygen Delivery, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate patient comfort and oxygen delivery efficiency when providing supplemental oxygen through a nasal cannula to volunteers using an instrumented oxygen delivery system. The goals of the study are to evaluate different oxygen flow rates and oxygen delivery modes. In addition, the investigators will investigate if the system can detect apnea (cessation of breathing) and removal of the nasal cannula. The investigators will also investigate how well high flow oxygen delivered only during inspiration is tolerated and how much the end-tidal oxygen increases after two minutes of high oxygen flow delivered only during the inhalation phase of the breath.
Primary Outcome
Did the novel system increase end-tidal oxygen?
Conditions Studied
Interventions
- DEVICE Supplemental Oxygen Delivery System
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-08 |
What the finished NCT02886312 record still lists
NCT02886312 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 3 conditions, with Patient Comfort appearing as the primary indexed condition, and to 1 intervention - of which Supplemental Oxygen Delivery System is the first listed.
NCT02886312 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT02886312 about?
NCT02886312 is a clinical study titled "Evaluation of Oxygen Delivery Through Nasal Cannula in Volunteers". This study will evaluate patient comfort and oxygen delivery efficiency when providing supplemental oxygen through a nasal cannula to volunteers using an instrumented oxygen delivery system. The goals of the study are to evaluate different oxygen flow rates and oxygen delivery modes. In addition, th...
What is the current status of trial NCT02886312?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2015-08. Estimated completion is 2016-08.
What conditions does trial NCT02886312 study?
This clinical trial studies the following conditions: Patient Comfort, Oxygen Delivery, Patient Monitoring.
What interventions are being tested in trial NCT02886312?
The interventions under investigation include: Supplemental Oxygen Delivery System (DEVICE).
Who is sponsoring clinical trial NCT02886312?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02886312 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Comfort
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia